Form 8-K - Current report:
SEC Accession No. 0001104659-21-135372
Filing Date
2021-11-08
Accepted
2021-11-08 08:10:15
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132165d1_8k.htm   iXBRL 8-K 27905
2 EXHIBIT 99.1 tm2132165d1_ex99-1.htm EX-99.1 110878
6 GRAPHIC tm2132165d1_ex99-1img01.jpg GRAPHIC 4734
  Complete submission text file 0001104659-21-135372.txt   330360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20211108.xsd EX-101.SCH 3239
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20211108_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20211108_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132165d1_8k_htm.xml XML 3473
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 211386599
SIC: 2834 Pharmaceutical Preparations